Neutral impactCompany

Par Drugs and Chemicals Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·8 Oct 2026, 11:21 am
PAR Drugs AND Chem

Par Drugs and Chemicals Limited has informed the stock exchanges that it has received a Certificate of Registration under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance confirms that the company has met the necessary requirements to operate as a Depository Participant, a role that facilitates the holding and transfer of securities in electronic form.

This development is a routine regulatory milestone for the company. For investors, it signifies that Par Drugs is fully compliant with market infrastructure rules, which is essential for the smooth functioning of its securities services. It reinforces the company's adherence to corporate governance standards and operational readiness within the depository ecosystem.

Investors should monitor the company's future announcements regarding the commencement of its depository services. This registration is a prerequisite for the actual launch of these services, which could potentially open new revenue streams and expand the company's business portfolio in the financial services sector.

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns PAR Drugs AND Chem (PAR).
  • Category: Company.

Why it matters

A routine update for PAR Drugs AND Chem. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.